Campral Approval History
- FDA approved: Yes (First approved July 29th, 2004)
- Brand name: Campral
- Generic name: acamprosate calcium
- Dosage form: Delayed-Release Tablets
- Company: Allergan, Inc.
- Treatment for: Alcohol Dependence
Campral (acamprosate calcium) is a synthetic compound resembling the endogenous amino acid homotaurine indicated for treating alcohol dependence.
Development History and FDA Approval Process for Campral
|Jul 29, 2004||Campral Forest Laboratories, Inc. and Merck - Treatment for Alcoholism|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.